Macquarie Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Macquarie Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-41,177	Closed	-$769	–	2654
2022 Q1	$769	Sell	41,177 -1,635,701	-98%	-$29.4M	﹤0.01%	1591
2021 Q4	$35.9M	Sell	1,676,878 -217,383	-11%	-$4.28M	0.03%	595
2021 Q3	$35M	Buy	1,894,261 +427,291	+29%	+$8.6M	0.03%	617
2021 Q2	$31.4M	Buy	+1,466,970	New	+$29.8M	0.03%	666

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group's OCDX Position: Q2 2022 in Review

Macquarie Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 41,177 shares — an estimated $769 sold.

Macquarie Group first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $35.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Macquarie Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Macquarie Group sold 41,177 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $769.
Macquarie Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
Macquarie Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $35.9M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.